Simon Moulton earned his Ph.D. in chemistry at the University of Wollongong in 2002. He is currently a professor in the Biomedical Engineering at the School of Engineering, Swinburne University of Technology. In addition, he serves as a bioengineering program leader at the Iverson Health Research Innovation Institute at the same institution. Simon Moulton is committed to solving human health conditions through implementing novel bioengineering practices. He focuses on the development of biodevices and biomaterials that provide delivery of therapeutic agents to aid in the treatment of cancer and the regeneration of damaged muscle, nerve, and cartilage. Over the past 20 years, Simon Moulton has developed vibrant and productive research teams across two institutions (University of Wollongong and Swinburne University of Technology) working on materials and devices for medical solutions.
Dr. Bita Zaferanloo is a microbial biotechnologist and senior lecturer in the Department of Chemistry and Biotechnology at Swinburne University of Technology, Australia. She holds a Ph.D. in Biotechnology–Microbiology and a graduate certificate in Learning and Teaching for Higher Education. Dr. Zaferanloo is dedicated to pioneering sustainable solutions that address global challenges in human health, agriculture, and environmental preservation. Her research spans a wide range of topics, including the exploration of novel bioactive compounds sourced from endophytes indigenous to Australian flora. She investigates their potential applications in plant protection, combating drug-resistant bacteria, and enhancing food nutrition. Furthermore, Dr. Zaferanloo is studying the role of endophytes in supporting agricultural systems in extreme environments, such as space agriculture, and exploring their therapeutic potential in biomedical applications, including cancer and dental treatments, through endophyte-derived nanoparticles and proteins. Leveraging artificial intelligence, Dr. Zaferanloo analyses complex biological data, optimises the discovery of novel bioactive compounds, and advances the development of sustainable, AI-driven solutions in biotechnology. Her multidisciplinary approach combines scientific inquiry with innovation and sustainability, aiming to advance both research and education in biotechnology and its diverse applications.
